RecruitingNot Applicable

Ion Therapy Patient Registry

Austria2,800 participantsStarted 2016-12

Plain-language summary

The purpose of the study is the prospective and standardized data collection of patients treated with ion therapy at MedAustron.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with tumor disease treated with ion beam therapy at MedAustron * Signed informed consent form Exclusion Criteria: * Comorbidities endangering treatment delivery or study compliance

What they're measuring

Therapy response

Timeframe: 10 years

Overall survival

Timeframe: 10 years

Progression-free survival

Timeframe: 10 years

Local progression-free survival

Timeframe: 10 years

Cause-specific survival

Timeframe: 10 years

Toxicity according to NCI CTCAE

Timeframe: 10 years

Trial details

NCT IDNCT03049072

SponsorEBG MedAustron GmbH

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2031-12

Contact for this trial

Yvonne Goy, MD

+43 2622 26 100 yvonne.goy@medaustron.at

View on ClinicalTrials.gov More Ion Beam Radiation Therapy for Tumor Patients trials